Clay Siegall Is Changing The Way That Cancer Is Being Dealt With

Clay Siegall is the co-founder, CEO, President, and Chairman of the Board of Seattle Genetics. He has training as a scientist who has studied targeted cancer therapies and built the company to help people through scientific discovery, diligent research, and developing helpful drugs. The company has made more than $350 million through partnerships with Pfizer, Genentech (Roche), GlaxoSmithKline, and AbbVie and continues to develop antibody-drug-conjugates (ADCs). Its first ADC product was ADCETRIS, which was approved by the FDA in 2011. This ADC has now reached a global audience has been approved for sale in over 65 countries.

Before helping to put together Seattle Genetics, during 1988 to 1991, Clay Siegal worked with the National Cancer Institute and the National Institutes of Health and also Bristol-Myers Squibb Pharmaceutical Research Institute for six years following this. He has 15 patents and has authored over 70 publications and also earned a Bachelor’s of Science in Zoology during his time with the University of Maryland and a Ph.D. from George Washington University in Genetics. He has received many different awards and a couple of these include the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year and the 2013 University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences.

Clay Seigall got into the business of creating ADCs because he has always had an interest in medicine and believes that technology can help the modern world overcome many different kinds of disease. His interest in helping to find treatment for cancer came from a family member who got the disease and then almost died from the conventional form of treatment; chemotherapy. This spurred him to began learning about other kinds of cancer treatment, which he found just as terrible, and it was then that he became motivated to find a better way to help people who suffered with cancer.

Clay Siegall also said that while money has not been the main motivation for his interest in fighting cancer, that it is nice to be able to be your own boss while working to help other people. He believes that it has been through hard work, rather than skill and talent, alone, that he has been able to become the success that he is today.

Leave a Reply

Your email address will not be published. Required fields are marked *